[Efficacy of thalidomide in digestive bleeding caused by angiodysplasias].
Fernández Salazar
L I
LI
Velayos Jiménez
B
B
Fernández Galante
I
I
Aller de la Fuente
R
R
González Hernández
J M
JM
D000368:Aged; D016888:Angiodysplasia / Q000150:complications* / Q000175:diagnosis; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000150:complications; D002528:Cerebellar Neoplasms / Q000150:complications; D002530:Cerebellopontine Angle; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007410:Intestinal Diseases / Q000150:complications* / Q000175:diagnosis; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications; D008577:Meningeal Neoplasms / Q000150:complications; D008579:Meningioma / Q000150:complications; D009378:Neoplasms, Multiple Primary; D013792:Thalidomide / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D013792:Thalidomide